Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,929 papers from all fields of science
Search
Sign In
Create Free Account
Oxacillin
Known as:
Oxacilline
, 6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid
, (2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Expand
A semisynthetic penicillinase-resistant and acid-stable penicillin with an antimicrobial activity. Oxacillin binds to penicillin-binding proteins in…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
33 relations
Broader (1)
Anti-Bacterial Agents
Bacterial Endocarditis
Bacterial Infections
Cellulitis
Drug Allergy
Expand
Narrower (4)
Oxacillin Sodium
Prostaphlin
broadcillin
optocillin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).
Ronald N. Jones
,
Matthew G. Stilwell
,
H. Sader
,
T. Fritsche
,
B. Goldstein
Diagnostic microbiology and infectious disease
2006
Corpus ID: 44994970
Review
2006
Review
2006
Pharmacologic characteristics of prulifloxacin.
M. Matera
Pulmonary Pharmacology & Therapeutics
2006
Corpus ID: 44703772
Highly Cited
2005
Highly Cited
2005
Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program.
T. Anderegg
,
H. Sader
,
T. Fritsche
,
J. E. Ross
,
Ronald N. Jones
International Journal of Antimicrobial Agents
2005
Corpus ID: 25720574
Highly Cited
2005
Highly Cited
2005
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
T. Fritsche
,
H. Sader
,
Matthew G. Stilwell
,
M. Dowzicky
,
Ronald N. Jones
Diagnostic microbiology and infectious disease
2005
Corpus ID: 25083268
Highly Cited
2004
Highly Cited
2004
Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society…
M. Kresken
,
D. Hafner
,
F. Schmitz
,
T. Wichelhaus
International Journal of Antimicrobial Agents
2004
Corpus ID: 23557006
Highly Cited
2002
Highly Cited
2002
A multicenter evaluation of linezolid antimicrobial activity in North America.
C. Ballow
,
Ronald N. Jones
,
D. Biedenbach
Diagnostic microbiology and infectious disease
2002
Corpus ID: 10192805
Highly Cited
2002
Highly Cited
2002
Combinations of Lysostaphin with β-Lactams Are Synergistic against Oxacillin-Resistant Staphylococcus epidermidis
Nandini Kiri
,
G. Archer
,
M. Climo
Antimicrobial Agents and Chemotherapy
2002
Corpus ID: 23987832
ABSTRACT Oxacillin-resistant Staphylococcus aureus is rapidly killed by the endopeptidase lysostaphin, and the addition of…
Expand
Highly Cited
1999
Highly Cited
1999
Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains.
I. Stock
,
Bernd Wiedemann
Diagnostic microbiology and infectious disease
1999
Corpus ID: 9529037
Highly Cited
1995
Highly Cited
1995
Primary structure of OXA-3 and phylogeny of oxacillin-hydrolyzing class D beta-lactamases
F. Sanschagrin
,
F. Couture
,
R. Lévesque
Antimicrobial Agents and Chemotherapy
1995
Corpus ID: 1436443
We determined the nucleotide sequence of the blaOXA-3(pMG25) gene from Pseudomonas aeruginosa. The bla structural gene encoded a…
Expand
Highly Cited
1970
Highly Cited
1970
Microbioassay of antimicrobial agents.
H. Simon
,
E. Yin
Applied microbiology
1970
Corpus ID: 40375126
A previously described agar-diffusion technique for microbioassay of antimicrobial agents has been modified to increase…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE